RSS
23 May 2023

Eisai Delivers New Data and Highlights Continued Progress of Oncology Portfolio and Pipeline at ASCO 2023

Author: admintech | Filed under: Press Release

Final Pre-Specified Overall Survival Analysis from the Pivotal Phase 3 CLEAR Trial in Patients with Advanced Renal Cell Carcinoma Will Be Featured in an Oral Presentation NUTLEY, N.J., May 23, 2023 /PRNewswire/ — Eisai announced today the presentation of research across various types of…

This entry was posted on Tuesday, May 23rd, 2023 at 7:12 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»